Efficacy and safety of lumbrokinase plus aspirin versus aspirin alone for acute ischemic stroke (LUCENT): study protocol for a multicenter randomized controlled trial

Efficacy and safety of lumbrokinase plus aspirin versus aspirin alone for acute ischemic stroke (LUCENT): study protocol for a multicenter randomized controlled trial

Abstract Background Lumbrokinase has been widely used for patients with acute ischemic stroke (AIS) in China; however, because rigorously designed studies are lacking, safety and efficacy of lumbrokinase in the treatment of acute ischemic stroke remains largely unknown. In this multicenter, randomiz...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Ying Chen, Yan Liu, Jingjing Zhang, Kehua Zhou, Xuecheng Zhang, Hengheng Dai, Baolin Yang, Hongcai Shang
Materialtyp: Artikel
Språk:English
Publicerad: BMC 2022-04-01
Serie:Trials
Ämnen:
Lumbrokinase
Aspirin
Acute ischemic stroke
Multicenter randomized controlled trial
Trial protocol
Länkar:https://doi.org/10.1186/s13063-022-06200-4

Internet

https://doi.org/10.1186/s13063-022-06200-4

Liknande verk